Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Patients with inflammatory arthritis reported significant loneliness and longed for their doctors to recognize their ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Managing psoriasis and psoriatic arthritis during the summer involves staying cool, using gentle skin care, and knowing what ...

Get an expert’s answers to common questions about how physical therapy can help with psoriatic arthritis, and learn how to get started. Living with psoriatic arthritis can mean chronic joint ...

Understand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...

ndorms.ox.ac.uk Background Psoriatic arthritis (PsA) recommendations state that the target of treatment should be remission or low disease activity (LDA). We used a real-life dataset to compare ...

Long COVID patients exhibit swelling in an area of the brain linked to memory problems, poor concentration and delayed responses during conversations, researchers have found. Based on high-powered ...

Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular ...

Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or ...

This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).